|
22 Dec 2020 |
Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases
|
|
22 Dec 2020 |
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
|
|
18 Dec 2020 |
Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T Cell Engager (TRACTr) Technology
|
|
18 Dec 2020 |
Histogen Announces Filing an Investigational New Drug Application for HST-003
|
|
18 Dec 2020 |
ONK Therapeutics Announces Three Exclusive Option License Agreements, Which Extend and Strengthen its Dual-Targeted NK Cell Therapy Pipeline
|
|
18 Dec 2020 |
Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases
|
|
18 Dec 2020 |
Leading BioSciences and Seneca Biopharma Announce Merger
|
|
16 Dec 2020 |
Lilly Announces Agreement to Acquire Prevail Therapeutics
|
|
14 Dec 2020 |
Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
|
|
12 Dec 2020 |
AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
|
|
10 Dec 2020 |
Gilead Sciences to Acquire MYR GmbH
|
|
10 Dec 2020 |
Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates
|
|
08 Dec 2020 |
Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes
|
|
08 Dec 2020 |
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
|
|
08 Dec 2020 |
Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH
|
|
08 Dec 2020 |
Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases
|
|
04 Dec 2020 |
Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies
|
|
04 Dec 2020 |
PharmaEngine, Inc. and Sentinel Oncology Limited Enter into an Exclusive Collaboration and License Agreement for SOL-578, a Chk1 inhibitor
|
|
03 Dec 2020 |
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
|
|
03 Dec 2020 |
Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation
|
|
02 Dec 2020 |
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
|
|
01 Dec 2020 |
Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies
|
|
01 Dec 2020 |
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
|
|
01 Dec 2020 |
Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
|
|
28 Nov 2020 |
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
|
